Wen-jie Wu

22# Zhongguancun South Avenue
Beijing, 100081, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Integrating clinicopathologic factors with whole-exome sequencing and peripheral immune repertoire sequencing to optimize decision-making in neoadjuvant chemoimmunotherapy for HNSCC.

Integrating clinicopathologic factors with whole-exome sequencing and peripheral immune repertoire sequencing to optimize decision-making in neoadjuvant chemoimmunotherapy for HNSCC.

Journal: Frontiers in immunology

Published: March 03, 2026

Preoperative Chemoimmunotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab for Previously Irradiated Recurrent HNSCC: A Prospective Phase II Trial.

Preoperative Chemoimmunotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab for Previously Irradiated Recurrent HNSCC: A Prospective Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 10, 2025

Single-cell sequencing reveals tumor microenvironment features associated with the response to neoadjuvant immunochemotherapy in oral squamous cell carcinoma.

Single-cell sequencing reveals tumor microenvironment features associated with the response to neoadjuvant immunochemotherapy in oral squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: February 04, 2025

Reconstruction of Defects After Oral Cancer Surgery With the Superior Thyroid Artery Perforator Flap.

Reconstruction of Defects After Oral Cancer Surgery With the Superior Thyroid Artery Perforator Flap.

Journal: The Laryngoscope

Published: January 20, 2024

Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.

Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.

Journal: Frontiers in immunology

Published: November 30, 2023

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.

Journal: Frontiers in immunology

Published: August 24, 2023

Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study.

Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study.

Journal: Frontiers in oncology

Published: August 07, 2023

Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.

Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.

Journal: Functional & integrative genomics

Published: February 02, 2023

Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing.

Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing.

Journal: Frontiers in genetics

Published: January 15, 2023

Deep learning-based two-step organs at risk auto-segmentation model for brachytherapy planning in parotid gland carcinoma.

Deep learning-based two-step organs at risk auto-segmentation model for brachytherapy planning in parotid gland carcinoma.

Journal: Journal of contemporary brachytherapy

Published: August 15, 2022

Image fusion technique for target volume delineation in 125I seed implant brachytherapy for parotid gland cancers.

Image fusion technique for target volume delineation in 125I seed implant brachytherapy for parotid gland cancers.

Journal: Journal of cancer research and therapeutics

Published: June 01, 2022

Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland.

Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland.

Journal: Translational cancer research

Published: August 29, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026